Cargando…
The demand for a COVID-19 vaccine in Ecuador
In Latin America, the country of Ecuador was one of the first and most severely affected by the COVID-19 pandemic. This study aimed to evaluate the demand for a COVID-19 vaccine in Ecuador by estimating individuals’ willingness to pay (WTP) for the vaccine, and by assessing the effect of vaccine att...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832521/ https://www.ncbi.nlm.nih.gov/pubmed/33187765 http://dx.doi.org/10.1016/j.vaccine.2020.11.013 |
_version_ | 1783641854871339008 |
---|---|
author | Sarasty, Oscar Carpio, Carlos E. Hudson, Darren Guerrero-Ochoa, Patricia A. Borja, Ivan |
author_facet | Sarasty, Oscar Carpio, Carlos E. Hudson, Darren Guerrero-Ochoa, Patricia A. Borja, Ivan |
author_sort | Sarasty, Oscar |
collection | PubMed |
description | In Latin America, the country of Ecuador was one of the first and most severely affected by the COVID-19 pandemic. This study aimed to evaluate the demand for a COVID-19 vaccine in Ecuador by estimating individuals’ willingness to pay (WTP) for the vaccine, and by assessing the effect of vaccine attributes (duration of protection and efficacy) and individuals’ characteristics on this valuation. The sample used (N = 1,050) was obtained through an online survey conducted from April 2 to April 7, 2020. Two levels of vaccine efficacy (70% and 98%) and two levels of vaccine duration of protection (1 and 20 years) were considered. The willingness to pay estimates were obtained using a double-bounded dichotomous-choice contingent valuation format. Survey results show that a very large proportion of individuals (at least 97%) were willing to accept a COVID-19 vaccine, and at least 85% of individuals were willing to pay a positive amount for that vaccine. Conservative estimates of the average WTP values ranged from USD 147.61 to 196.65 and the median WTP from USD 76.9 to 102.5. Only the duration of protection was found to influence individuals’ WTP for the vaccine (p < 0.01). On average, respondents were willing to pay 30% more for a COVID-19 vaccine with 20 years of protection relative to the vaccine with 1 year of protection. Regression results show that WTP for the vaccine was associated with income, employment status, the perceived probability of needing hospitalization if contracting the virus causing COVID-19, and region of residence. |
format | Online Article Text |
id | pubmed-7832521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78325212021-01-26 The demand for a COVID-19 vaccine in Ecuador Sarasty, Oscar Carpio, Carlos E. Hudson, Darren Guerrero-Ochoa, Patricia A. Borja, Ivan Vaccine Article In Latin America, the country of Ecuador was one of the first and most severely affected by the COVID-19 pandemic. This study aimed to evaluate the demand for a COVID-19 vaccine in Ecuador by estimating individuals’ willingness to pay (WTP) for the vaccine, and by assessing the effect of vaccine attributes (duration of protection and efficacy) and individuals’ characteristics on this valuation. The sample used (N = 1,050) was obtained through an online survey conducted from April 2 to April 7, 2020. Two levels of vaccine efficacy (70% and 98%) and two levels of vaccine duration of protection (1 and 20 years) were considered. The willingness to pay estimates were obtained using a double-bounded dichotomous-choice contingent valuation format. Survey results show that a very large proportion of individuals (at least 97%) were willing to accept a COVID-19 vaccine, and at least 85% of individuals were willing to pay a positive amount for that vaccine. Conservative estimates of the average WTP values ranged from USD 147.61 to 196.65 and the median WTP from USD 76.9 to 102.5. Only the duration of protection was found to influence individuals’ WTP for the vaccine (p < 0.01). On average, respondents were willing to pay 30% more for a COVID-19 vaccine with 20 years of protection relative to the vaccine with 1 year of protection. Regression results show that WTP for the vaccine was associated with income, employment status, the perceived probability of needing hospitalization if contracting the virus causing COVID-19, and region of residence. Elsevier Ltd. 2020-12-03 2020-11-06 /pmc/articles/PMC7832521/ /pubmed/33187765 http://dx.doi.org/10.1016/j.vaccine.2020.11.013 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Sarasty, Oscar Carpio, Carlos E. Hudson, Darren Guerrero-Ochoa, Patricia A. Borja, Ivan The demand for a COVID-19 vaccine in Ecuador |
title | The demand for a COVID-19 vaccine in Ecuador |
title_full | The demand for a COVID-19 vaccine in Ecuador |
title_fullStr | The demand for a COVID-19 vaccine in Ecuador |
title_full_unstemmed | The demand for a COVID-19 vaccine in Ecuador |
title_short | The demand for a COVID-19 vaccine in Ecuador |
title_sort | demand for a covid-19 vaccine in ecuador |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832521/ https://www.ncbi.nlm.nih.gov/pubmed/33187765 http://dx.doi.org/10.1016/j.vaccine.2020.11.013 |
work_keys_str_mv | AT sarastyoscar thedemandforacovid19vaccineinecuador AT carpiocarlose thedemandforacovid19vaccineinecuador AT hudsondarren thedemandforacovid19vaccineinecuador AT guerreroochoapatriciaa thedemandforacovid19vaccineinecuador AT borjaivan thedemandforacovid19vaccineinecuador AT sarastyoscar demandforacovid19vaccineinecuador AT carpiocarlose demandforacovid19vaccineinecuador AT hudsondarren demandforacovid19vaccineinecuador AT guerreroochoapatriciaa demandforacovid19vaccineinecuador AT borjaivan demandforacovid19vaccineinecuador |